PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors Should Contact SueWallSt

SueWallSt alerts investors in Insulet Corporation (NASDAQ: PODD) of a pending securities class action naming senior executives as individual defendants.

Insulet shares declined from $236.07 to $146.01 following two Medical Device Corrections, resulting in an approximate $90 per share decline from pre-disclosure levels.

Six senior officers of Insulet Corporation are named as individual defendants in the securities class action filed in the United States District Court for the District of Massachusetts: Ashley A. McEvoy — President, CEO, and Director (April 28, 2025 to present). McEvoy certified SEC filings under Sarbanes-Oxley Sections 302 and 906 while allegedly assuring investors that Insulet produced "tens of millions of Pods with high-quality medical-grade quality" and that the Company's manufacturing delivered products "at medical standards."

James R. Hollingshead — Former President, CEO, and Director (through April 28, 2025). Hollingshead allegedly told investors "it took us years to build a patch pump product at scale with quality, high yield, safety" during the February 2025 earnings call.

Flavia H. Pease — EVP and CFO (September 30, 2025 to present). Pease signed quarterly and annual SEC filings containing allegedly misle...